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ABSTRACT 
Diazepam orodispersible tablets were prepared to achieve quick onset of action and for maximum bioavailability. The purpose of the present research was to 
compare the effect of different superdisintegrants on the mouth dissolving property of diazepam tablets. Orodispersible tablets of diazepam were prepared 
using  chitosan,  sodium  carboxy  methyl  cellulose,  alginic  acid,  crospovidone  and  sodium  starch  glycollate  as  superdisintegrants  by  direct  compression 
technique.  Prepared  tablets  were  evaluated  for  weight  variation,  hardness,  friability,  content  uniformity,  wetting  time,  in  vitro  dispersion  time,  in  vitro 
disintegration time and dissolution studies. Disintegration time from all the prepared formulation was found to be in following order: F2<F5<F1<F4<F3. 
Disintegration time was found to be rapid in F2 formulation. The in vitro dissolution time was found to be 99.91% in 10 minutes for the formulation F2. 
Crospovidone showed faster disintegration of tablets among all other superdisintegrants. 
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INTRODUCTION 
The tablet is the most widely used dosage form because of its 
convenience  in  terms  of  self-  administration,  compactness, 
and  ease  in  manufacturing.  Orodispersible  tablets  are 
uncoated tablets intended to be placed in the mouth where 
they disperse rapidly before being swallowed. Orodispersible 
tablets undergo disaggregating in the mouth when in contact 
with the saliva in less than 60 seconds, preferably in less than 
40 seconds, forming a suspension which is easy to swallow. 
The  target  population  for  these  new  fast-dissolving  / 
disintegrating  dosage  forms  has  generally  been  pediatric, 
geriatric,  and  bedridden  or  mentally  disabled  patients.  A 
major  claim  of  some  orodispersibles  is  increased 
bioavailability  compared  to  traditional  tablets.  Because  of 
dispersion in saliva while still in the oral cavity, there can be 
pregastric absorption from some formulation, in cases where 
the  drug  dissolves  quickly.  Buccal,  pharyngeal  and  gastric 
regions  are  areas  of  absorption  of  the  formulation
1-4. 
Objective of present study was to develop such as novel drug 
delivery  systems  for  diazepam  by  simple  &  cost  effective 
direct  compression  method.  Chitosan,  sodium  carboxy 
methyl  cellulose,  alginic  acid,  crospovidone  and  sodium 
starch  glycollate  were  used  as  superdisintegrant  in  the 
formulation  for  faster  disintegration.  Micro  crystalline 
cellulose (MCC) is used as diluents and disintigrant. It is one 
of  the  fastest  growing  segments  in  the  pharmaceutical 
market
3,4,11. 
Diazepam  is  an  important  member  of  the  group  of  1,4- 
benzodiazepine  derivatives.  Diazepam  exerts  anxiolytic, 
anticonvulsant,  sedative,  muscle-relaxant  and  amnestic 
effects. It is a colorless to light yellow crystalline compound 
insoluble in water 
5,15. 
MATERIALS AND METHODS 
Materials 
Diazepam  was  received  as  a  gift  sample  from  Ronak 
Pharmaceuticals  pvt  Ltd.,  Patan.  Chitosan,  magnesium 
stearate,  talc,  orange  flavour,  sodium  carboxy  methyl 
cellulose  (sodium  CMC),  alginic  acid,  micro  crystalline 
cellulose (MCC), crospovidone and sodium starch glycollate 
(SSG)  were  purchased  from  Central  Drug  House  (P)  Ltd., 
New Delhi. 
Method
 4,7,14,15 
Tablets were prepared by direct compression technique. The 
composition orodispersible tablet of Diazepam was shown in 
Table  1.  Weighed  quantities  of  Diazepam  along  with 
appropriate  concentrations  of  superdisintegrants  along  with 
excipients were weighed and mixed in geometric progression 
in a dry and clean mortar. Then the blend was passed through 
sieve  no  60  for  direct  compression. The  powder  blend  for 
direct compression was then compressed into tablets using 8 
mm  convex  faced  punches  in  a  10  Station  Rotary  Tablet 
Machine. These Fabricated tablets were evaluated. 
EVALUATION 
Weight variation test
6,9,11 
20 tablets were selected at random, individually weighed and 
the  average  weight  was  calculated.  None  of  the  tablets 
deviated from the average weight by more than ±7.5%. 
Hardness test
7,9 
Tablets require a certain amount of strength or hardness and 
resistance to friability to with stand mechanical shocks. The 
hardness  of  tablet  was  measured  by  Monsanto  hardness 
tester. 
Friability
6,8,11 
Twenty  tablets  were  weighed  and  placed  in  a  Roche 
friabilator and the equipment was rotated at 25 rpm for 4 min. 
The  tablets  were  taken  out,  dedusted,  and  reweighed.  The 
percentage friability of the tablets was calculated by 
 
Content uniformity
9,15 
The  content  of  diazepam  was  determined according to  the 
method described by BP for diazepam tablets. In brief, 1 ml 
of water was added to one diazepam tablet, stood for 15 min, 
then  80  ml  of  a  0.5%  (w/v)  solution  of  sulfuric  acid  in 
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the volume was adjusted to 100 ml with 0.5% (w/v) solution 
of  sulfuric  acid  in  methanol.  The  filtrated  solution  was 
diluted  appropriately  and  the  drug  content  was  measured 
spectrophotometrically at 284 nm. 
Wetting time
10,18 
A piece of tissue paper folded twice was placed in a small 
Petri dish containing 6 ml of water. A tablet was put on the 
paper  &  the  time  required  for  complete  wetting  was 
measured.  
In Vitro Dispersion Time
11,12,15 
In vitro dispersion time was measured by dropping a tablet in 
a measuring cylinder containing 6 ml of phosphate buffer pH 
6.8  (simulated  saliva  fluid).  The  time  for  the  tablet  to 
completely  disintegrate  into  fine  particles  was  noted.  Six 
tablets from each batch were randomly selected and in vitro 
dispersion time was performed. 
In Vitro Disintegration Time
11,13,15 
The disintegration time of the tablets was determined as per 
Indian  Pharmacopoeia  monograph.  The  time  required  for 
disintegration of six tablets from each batch placed in each 
tube  of  disintegration  test  apparatus  were  measured  at 
37±0.5°C using 900 ml of distilled water. The time required 
to  obtain complete disintegration of all the six tablets was 
noted. 
Dissolution Studies
14,15,16,17 
In  vitro  dissolution  studies  were  performed  using  type  II 
(paddle)  dissolution  apparatus  at  100  rpm,  and  900  ml  of 
phosphate buffer (pH 6.8) was used as a dissolution medium. 
Temperature  of  dissolution  medium  was  maintained  at 
37±0.5°C. Five milliliters aliquot of the dissolution medium 
was  withdrawn  at  specific  time  intervals.  Absorption  of 
filtered  solution  was  measured  by  UV–visible 
spectrophotometer  at  275  nm,  and  the  percent  of  drug 
released  was  determined  using  standard  curve.  Dissolution 
rate was studied for the prepared formulations. 
RESULTS 
Formulations  were  prepared  by  direct  compression 
techniques using different disintegrating agents are shown in 
Table 1. Parameters like weight variation, hardness, friability, 
drug content, wetting time, in vitro dispersion time and in 
vitro  disintegration  are  mentioned  in  Table  2.  All 
formulations  evaluated  for  variation  in  weight  and  results 
indicated  that  for  all  formulations  exhibit  very  low  weight 
variation which lies within the pharmacopoeia limits i.e. ± 
7.5%. The tablets measured hardness was found to be in the 
range of 3.2 to 3.6 kg/cm
2. The percentage friability was less 
than 1% for all formulation ensuring mechanical stability of 
the  formulated  tablets.  Content  uniformity  in  all  the 
formulations were found in the range of 9.61 ± 0.33 to 9.94 ± 
0.65  indicating  the  compliance  with  the  pharmacopoeia 
limits. In Vitro disintegration time was found to be in range 
of  18  to  31  second.  According  to  the  pharmacopoeia 
standards the dispersible tablet must disintegrate within 3 min 
but  all  formulated  batches  have  shown  very  low 
disintegration  time  indicating  suitability  of  formulation  for 
fast  dissolving  tablet.  Disintegration  time  from  all  the 
prepared  formulation  was  found  to  be  in  following  order: 
F2<F5<F1<F4<F3.  Disintegration  time  of  various 
formulations  is  mentioned  in  Figure  1.  Wetting  time  was 
found to be in range of 24 to 36 second. In vitro dispersion 
time  was  found  to  be  in  range  of  21  to  36  second.  % 
Cumulative  drug release  from  all  the  prepared  formulation 
was  found to be in following order: F2>F1>F3>F5>F4. % 
Cumulative  drug release  from  F1,  F2 and  F5  formulations 
were  found  to  be  in  10  minute  and  from  F3  and  F5 
formulations were found to be in 12 minutes. Formulation F2 
shows  fast  disintegration  and  high  %  Cumulative  drug 
release. 
DISCUSSION  
Different  formulations  were  prepared  using  10% 
superdisintegrant  like  chitosan,  sodium  carboxy  methyl 
cellulose,  alginic  acid,  crospovidone  and  sodium  starch 
glycollate.  The  tablets  prepared  by  direct  compression 
technique were found to have adequate hardness, friability, 
content uniformity, wetting time and in vitro dispersion time. 
Prepared tablets disintegrate within few seconds without need 
of water; thereby enhance absorption resulting in increased 
bioavailability and increased patient compliance. Among all 
the superdisintegrant crospovidone showed maximum effect 
of  disintigrantion.  Effect  of  superdisintegrant  from  all  the 
prepared  formulation  was  found  to  be  in  following  order: 
Crospovidone>SSG>Sodium  CMC>Chitosan>Alginic  acid. 
The formulated tablet F2 showed fast disintegration and in 
vitro dissolution. Therefore these tablets which possess rapid 
disintegration  may  be  useful  for  pediatric  and  geriatric 
population.  
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Table 1: Composition of orodispersible tablets of Diazepam 
BATCH 
CORD 
INGREDIANT (mg) 
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F1  10  20  -  -  -  -  55  109  2  2  2 
F2  10  -  20  -  -  -  55  109  2  2  2 
F3  10  -  -  20  -  -  55  109  2  2  2 
F4  10  -  -  -  20  -  55  109  2  2  2 
F5  10  -  -  -  -  20  55  109  2  2  2 
 
Table 2: Evaluation of Diazepam orodispersible tablets 
TESTS  BATCH CORD 
F1  F2  F3  F4  F5 
Weight variation (mg)  Pass  Pass  Pass  Pass  Pass 
Hardness kg/cm
2  3.3  3.6  3.2  3.4  3.2 
% Friability  0.49  0.35  0.62  0.42  0.66 
Content uniformity (mg)  9.74 ± 0.43  9.94 ± 0.65  9.68 ± 0.25  9.85 ± 0.46  9.61 ± 0.33 
Wetting time (second)  29  24  36  33  28 
In Vitro dispersion time (second)  28  21  36  32  25 
In Vitro Disintegration Time  24  18  31  27  22 
 
Table 3: In vitro dissolution studies of orodispersible tablets of Diazepam 
Time 
(min) 
% Cumulative drug release 
F1  F2  F3  F4  F5 
2  54.34 ± 0.87  58.48 ± 0.65  48.76 ± 0.76  52.64 ± 0.66  50.33 ± 0.74 
4  63.76 ± 0.46  67.75 ± 0.86  61.39 ± 0.39  65.73 ± 0.73  64.87 ± 0.63 
6  78.65 ± 0.29  80.39 ± 0.48  75.58 ± 0.42  73.84 ± 0.26  79.64 ± 0.77 
8  95.96 ± 0.84  97.57 ± 0.51  84.84 ± 0.63  83.33 ± 0.64  96.84 ± 0.45 
10  98.87 ± 0.35  99.91 ± 0.23  92.76 ± 0.76  93.72 ± 0.54  97.99 ± 0.76 
12  -  -  98.24 ± 0.65  97.47 ± 0.88  - 
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Figure 1: In vitro disintegration profile of F1 to F5. 
 
 
 
 
Figure 2: In vitro release profile for F1 to F5. 
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